Suppr超能文献

亲水性和两亲性大分子作为吡贝地尔物理稳定性和生物利用度的调节剂:二元混合物和胶束系统的研究

Hydrophilic and Amphiphilic Macromolecules as Modulators of the Physical Stability and Bioavailability of Piribedil: A Study on Binary Mixtures and Micellar Systems.

作者信息

Orszulak Luiza, Minecka Aldona, Bernat Roksana, Lamrani Taoufik, Jurkiewicz Karolina, Hachuła Barbara, Tarnacka Magdalena, Geppert-Rybczyńska Monika, Zubko Maciej, Staniszewska Marcela, Smoleński Michał, Dobosz Justyna, Garbacz Grzegorz, Kamiński Kamil, Kamińska Ewa

机构信息

Institute of Chemistry, Faculty of Science and Technology, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, Poland.

Department of Pharmacognosy and Phytochemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellonska 4, 41-200 Sosnowiec, Poland.

出版信息

Mol Pharm. 2025 Aug 4;22(8):4708-4730. doi: 10.1021/acs.molpharmaceut.5c00276. Epub 2025 Jun 30.

Abstract

This study presents an innovative approach that utilizes polymers with different topologies and properties as potential matrices for the poorly water-soluble active pharmaceutical ingredient piribedil (PBD). We investigated amorphous solid dispersions (ASDs) as well as micellar systems composed of PBD and () the commercial amphiphilic copolymer Soluplus, () self-synthesized hydrophilic linear PVP (PVP), and () self-synthesized hydrophilic star-shaped PVP (PVP). Differential scanning calorimetry, X-ray diffraction, Fourier-transform infrared, and broadband dielectric spectroscopy were applied to gain comprehensive insights into the thermal and structural properties, intermolecular interactions, global molecular dynamics, and recrystallization of the API from the amorphous PBD-polymer ASDs. The primary objective was to evaluate the impact of the type and topology of macromolecules, as well as the composition of binary formulations, on the physical stability of PBD in the amorphous form, phase transition temperatures, the API's recrystallization rate, and ultimately, the release of drug in the prepared ASDs and micelles. Most importantly, our research led to the discovery of new polymorphic form (II) of PBD that has not been previously described in the scientific literature. We also revealed that ASDs containing hydrophilic PVP polymers exhibit the best performance in stabilizing the amorphous form of the API, with the PVP systems showing the highest stabilization effect. In contrast, for micellar systems, Soluplus turned out to be the most suitable candidate in terms of forming the self-assembles of the lowest size distribution among all systems. The long-term stability of the amorphous drug in PBD-Soluplus micelles was higher compared to PBD-PVP ASD. Moreover, an improvement in the bioavailability of the API contained in all tested formulations (binary and micellar systems) was observed, with PBD-PVP micelles exhibiting the most desirable drug release profile within the polymer matrix, as well as the highest concentration of released drug. The obtained data highlight the crucial role of the type and topology/architecture of the polymer in the design of novel pharmaceutical formulations.

摘要

本研究提出了一种创新方法,该方法利用具有不同拓扑结构和性质的聚合物作为难溶性活性药物成分吡贝地尔(PBD)的潜在基质。我们研究了无定形固体分散体(ASD)以及由PBD与()商业两亲共聚物Soluplus、()自合成的亲水性线性聚乙烯吡咯烷酮(PVP)和()自合成的亲水性星形聚乙烯吡咯烷酮(PVP)组成的胶束系统。应用差示扫描量热法、X射线衍射、傅里叶变换红外光谱和宽带介电谱,以全面深入了解无定形PBD-聚合物ASD中活性药物成分(API)的热性能和结构性能、分子间相互作用、整体分子动力学以及重结晶情况。主要目的是评估大分子的类型和拓扑结构以及二元制剂的组成对无定形形式的PBD的物理稳定性、相变温度、API的重结晶速率以及最终对所制备的ASD和胶束中药物释放的影响。最重要的是,我们的研究发现了PBD的一种新的多晶型形式(II),这在科学文献中尚未有过描述。我们还发现,含有亲水性PVP聚合物的ASD在稳定API的无定形形式方面表现出最佳性能,其中PVP系统显示出最高的稳定效果。相比之下,对于胶束系统,就形成所有系统中尺寸分布最低的自组装体而言,Soluplus是最合适的候选者。与PBD-PVP ASD相比,PBD-Soluplus胶束中无定形药物的长期稳定性更高。此外,观察到所有测试制剂(二元和胶束系统)中所含API的生物利用度有所提高,PBD-PVP胶束在聚合物基质中表现出最理想的药物释放曲线,以及最高的释放药物浓度。所获得的数据突出了聚合物的类型和拓扑结构/架构在新型药物制剂设计中的关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验